QCM
CRBU icon

Quantinno Capital Management’s Caribou Biosciences CRBU Stock Holding History

Quantinno Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8K Buy
+10,436
New +$17.9K ﹤0.01% 3294

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantinno Capital Management's CRBU Position: Q1 2026 in Review

Quantinno Capital Management opened a new position in Caribou Biosciences (CRBU) in Q1 2026: 10,436 shares worth $19.8K. The stake represents ﹤0.01% of the portfolio and ranks #3294 among its holdings.

137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Quantinno Capital Management held 10,436 shares of Caribou Biosciences worth $19.8K as of Q1 2026.
  • Caribou Biosciences was a new Quantinno Capital Management position in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3294 holding.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.